A Dual AMPK/Nrf2 Activator Reduces Brain Inflammation After Stroke by Enhancing Microglia M2 Polarization.

AIMS Microglia-mediated neuroinflammation plays an important role in focal ischemic stroke, a disorder with no effective therapeutic agents. Since microglial polarization to the M2 phenotype and reduction of oxidative stress are mediated through AMP-activated protein kinase (AMPK) and nuclear factor erythroid 2-related factor 2 (Nrf2) activation, we assessed the dual therapeutic effect of AMPK and Nrf2 activation by a novel neuroprotectant HP-1c in the treatment of ischemic stroke. RESULTS We developed a novel class of hybrids (HP-1a-HP-1f) of telmisartan and 2-(1-hydroxypentyl)-benzoate (HPBA) as a ring-opening derivative of NBP. The most promising hybrid, HP-1c, exhibited more potent anti-inflammatory and neuroprotective effects in vitro and reduced brain infarct volume and improved neurological deficits in a rat model of transient focal cerebral ischemia when compared with telmisartan alone, NBP alone, or a combination of telmisartan and NBP. HP-1c had a therapeutic window of up to 24 h, ameliorated ischemic cerebral injury in permanent focal cerebral ischemia, and improved motor function. The beneficial effects of HP-1c in ischemic stroke were associated with microglial polarization to the M2 phenotype and reduced oxidative stress. HP-1c also shifted the M1/M2 polarization in a mouse neuroinflammatory model. The anti-inflammatory and anti-oxidative effects of HP-1c were associated with AMPK-Nrf2 pathway activation for neuroprotection. We showed that HP-1c penetrates the brain, has a plasma half-life of around 3.93 h, and has no toxicity in mice. Innovation and Conclusion: Our study results suggest that HP-1c, with dual AMPK- and Nrf2-activating properties, may have potential in further studies as a novel therapy for ischemic stroke. Antioxid. Redox Signal. 28, 141-163.

[1]  Tao Pang,et al.  The natural product 4,10-aromadendranediol induces neuritogenesis in neuronal cells in vitro through activation of the ERK pathway , 2020, Acta Pharmacologica Sinica.

[2]  Siyu Chen,et al.  Hypolipidemic effect of oleanolic acid is mediated by the miR‐98‐5p/PGC‐1β axis in high‐fat diet‐induced hyperlipidemic mice , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Mengxue Xu,et al.  Nrf2—a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke , 2017, Molecular Neurobiology.

[4]  O. C. Oliveira-Lima,et al.  Vesicular acetylcholine transporter knock down-mice are more susceptible to inflammation, c-Fos expression and sickness behavior induced by lipopolysaccharide , 2016, Brain, Behavior, and Immunity.

[5]  Xin-Fu Zhou,et al.  Nafamostat mesilate improves function recovery after stroke by inhibiting neuroinflammation in rats , 2016, Brain, Behavior, and Immunity.

[6]  Qing-Wu Yang,et al.  Functions and mechanisms of microglia/macrophages in neuroinflammation and neurogenesis after stroke , 2016, Progress in Neurobiology.

[7]  J. Simard,et al.  The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia , 2016, Journal of Neuroinflammation.

[8]  Ja Hyun Koo,et al.  AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550 , 2016, Molecular and Cellular Biology.

[9]  Ting Zhang,et al.  Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke. , 2016, Experimental and therapeutic medicine.

[10]  Yu-bo Zhou,et al.  A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway , 2016, Acta Pharmacologica Sinica.

[11]  J. Saavedra.  Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer’s Disease , 2016, Cellular and Molecular Neurobiology.

[12]  G. Remuzzi,et al.  Regression of Renal Disease by Angiotensin II Antagonism Is Caused by Regeneration of Kidney Vasculature. , 2016, Journal of the American Society of Nephrology.

[13]  Ye Xu,et al.  Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model , 2016, Neurobiology of Aging.

[14]  X. Ji,et al.  Interleukin-4 Is Essential for Microglia/Macrophage M2 Polarization and Long-Term Recovery After Cerebral Ischemia , 2016, Stroke.

[15]  H. Duan,et al.  DL-3-n-butylphthalide delays the onset and progression of diabetic cataract by inhibiting oxidative stress in rat diabetic model , 2016, Scientific Reports.

[16]  Abdel G. Elkahloun,et al.  An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s disease , 2016, Alzheimer's Research & Therapy.

[17]  Ping Li,et al.  Totarol prevents neuronal injury in vitro and ameliorates brain ischemic stroke: Potential roles of Akt activation and HO-1 induction. , 2015, Toxicology and applied pharmacology.

[18]  J. Simard,et al.  Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis , 2015, Journal of Neuroinflammation.

[19]  Luyong Zhang,et al.  Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKKβ-dependent AMPK activation , 2015, Brain, Behavior, and Immunity.

[20]  A. Atanasov,et al.  Activated AMPK boosts the Nrf2/HO-1 signaling axis—A role for the unfolded protein response , 2015, Free radical biology & medicine.

[21]  J. D. Engel,et al.  Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation , 2015, Proceedings of the National Academy of Sciences.

[22]  Lin-na Wang,et al.  The edaravone and 3-n-butylphthalide ring-opening derivative 10b effectively attenuates cerebral ischemia injury in rats , 2015, Acta Pharmacologica Sinica.

[23]  Luyong Zhang,et al.  Development of a Novel Phosphorylated AMPK Protection Assay for High-Throughput Screening Using TR-FRET Assay , 2015, Journal of biomolecular screening.

[24]  M. Bennett,et al.  HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis , 2015, Proceedings of the National Academy of Sciences.

[25]  J. Suttles,et al.  Adenosine 5′-Monophosphate–Activated Protein Kinase Regulates IL-10–Mediated Anti-Inflammatory Signaling Pathways in Macrophages , 2015, The Journal of Immunology.

[26]  R. Leak,et al.  Microglial and macrophage polarization—new prospects for brain repair , 2015, Nature Reviews Neurology.

[27]  Xuechu Zhen,et al.  CaMKKβ-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation. , 2014, Antioxidants & redox signaling.

[28]  Jian Cheng,et al.  Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke , 2014, Brain, Behavior, and Immunity.

[29]  Jin-Tai Yu,et al.  Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre‐activation of AMPK‐dependent autophagy , 2014, British journal of pharmacology.

[30]  S. Weber,et al.  NRF2-regulation in brain health and disease: Implication of cerebral inflammation , 2014, Neuropharmacology.

[31]  Ling Wang,et al.  The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. , 2014, Antioxidants & redox signaling.

[32]  W. Yeh,et al.  Antineuroinflammatory effects of lycopene via activation of adenosine monophosphate-activated protein kinase-α1/heme oxygenase-1 pathways , 2014, Neurobiology of Aging.

[33]  S. Lipton,et al.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. , 2013, Free radical biology & medicine.

[34]  B. Brüne,et al.  Redox control of inflammation in macrophages. , 2013, Antioxidants & redox signaling.

[35]  Jide Tian,et al.  Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents. , 2013, Journal of medicinal chemistry.

[36]  D. Hardie,et al.  Metabolism of inflammation limited by AMPK and pseudo-starvation , 2013, Nature.

[37]  J. Saavedra.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. , 2012, Clinical science.

[38]  Xiaoli Wang,et al.  Studies on the enantiomers of ZJM-289: synthesis and biological evaluation of antiplatelet, antithrombotic and neuroprotective activities. , 2012, Organic & biomolecular chemistry.

[39]  R. Leak,et al.  Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia , 2012, Stroke.

[40]  Huiling Zhang,et al.  Direct protection of neurons and astrocytes by matrine via inhibition of the NF-κB signaling pathway contributes to neuroprotection against focal cerebral ischemia , 2012, Brain Research.

[41]  L. Cui,et al.  dl-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis , 2012, Neuropharmacology.

[42]  J. Saavedra,et al.  Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-&ggr; activation in human monocytes , 2012, Journal of hypertension.

[43]  A. Means,et al.  Characterization of the CaMKKβ-AMPK signaling complex. , 2011, Cellular signalling.

[44]  M. Modo,et al.  Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in stroke , 2011, The Journal of physiology.

[45]  Yihua Zhang,et al.  Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents. , 2011, Organic & biomolecular chemistry.

[46]  Renee E Haskew-Layton,et al.  Development of Neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of Nrf2 activators. , 2011, Chemistry & biology.

[47]  Yan Leng,et al.  Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation , 2011, Neuropsychopharmacology.

[48]  Hong Wang,et al.  Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. , 2011, American journal of physiology. Heart and circulatory physiology.

[49]  Ying Huang,et al.  Role of Nrf2 in suppressing LPS-induced inflammation in mouse peritoneal macrophages by polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid. , 2010, Molecular pharmaceutics.

[50]  Chih-Hsin Tang,et al.  Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microglia , 2010, Journal of cellular biochemistry.

[51]  Guohong Li,et al.  Inflammatory mechanisms in ischemic stroke: role of inflammatory cells , 2010, Journal of leukocyte biology.

[52]  M. Mattson,et al.  Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia , 2010, Journal of neurochemistry.

[53]  Y. Wang,et al.  dl-3-n-butylphthalide protects endothelial cells against oxidative/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro , 2009, Brain Research.

[54]  Gaochao Zhou,et al.  AMPK: an emerging drug target for diabetes and the metabolic syndrome. , 2009, Cell metabolism.

[55]  S. Nagahiro,et al.  Edaravone, a Free Radical Scavenger, Inhibits MMP-9–Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator , 2009, Stroke.

[56]  U. Dirnagl,et al.  REPRINT: Good Laboratory Practice: Preventing Introduction of Bias at the Bench , 2009, International journal of stroke : official journal of the International Stroke Society.

[57]  Marcel Leist,et al.  The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. , 2009, ALTEX.

[58]  Xiaohe Yang,et al.  Disruption of Nrf2 Enhances Upregulation of Nuclear Factor-κB Activity, Proinflammatory Cytokines, and Intercellular Adhesion Molecule-1 in the Brain after Traumatic Brain Injury , 2009, Mediators of inflammation.

[59]  J. Suttles,et al.  Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype1 , 2008, The Journal of Immunology.

[60]  F. Nan,et al.  AICAR Induces Astroglial Differentiation of Neural Stem Cells via Activating the JAK/STAT3 Pathway Independently of AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[61]  Y. Surh.  NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. , 2008, Asia Pacific journal of clinical nutrition.

[62]  Chunli Liu,et al.  dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP , 2007, Journal of the Neurological Sciences.

[63]  E. A. Bernard,et al.  Regulation of LPS stimulated ROS production in peritoneal macrophages from alloxan-induced diabetic rats: involvement of high glucose and PPARgamma. , 2007, Life sciences.

[64]  D. Greaves,et al.  Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. , 2006, Cell metabolism.

[65]  Y. Namiki,et al.  Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. , 2006, CNS drug reviews.

[66]  K. Kang,et al.  Molecular mechanism of nrf2 activation by oxidative stress. , 2005, Antioxidants & redox signaling.

[67]  Jin Liu,et al.  Recent pharmacological studies on natural products in China. , 2004, European journal of pharmacology.

[68]  B. Viollet,et al.  5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein Kinase , 2004, The Journal of Neuroscience.

[69]  B. Fermini,et al.  The impact of drug-induced QT interval prolongation on drug discovery and development , 2003, Nature Reviews Drug Discovery.

[70]  C. Bregonzio,et al.  Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT1 Antagonist , 2002, Stroke.

[71]  S. Holland,et al.  p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. , 2001, The Journal of clinical investigation.

[72]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.